These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Robson MC; Phillips LG; Thomason A; Altrock BW; Pence PC; Heggers JP; Johnston AF; McHugh TP; Anthony MS; Robson LE Ann Plast Surg; 1992 Sep; 29(3):193-201. PubMed ID: 1524367 [TBL] [Abstract][Full Text] [Related]
5. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study. Rees RS; Robson MC; Smiell JM; Perry BH Wound Repair Regen; 1999; 7(3):141-7. PubMed ID: 10417749 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Wieman TJ; Smiell JM; Su Y Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248 [TBL] [Abstract][Full Text] [Related]
7. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. Pierce GF; Tarpley JE; Tseng J; Bready J; Chang D; Kenney WC; Rudolph R; Robson MC; Vande Berg J; Reid P J Clin Invest; 1995 Sep; 96(3):1336-50. PubMed ID: 7657809 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Smiell JM; Wieman TJ; Steed DL; Perry BH; Sampson AR; Schwab BH Wound Repair Regen; 1999; 7(5):335-46. PubMed ID: 10564562 [TBL] [Abstract][Full Text] [Related]
9. Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers. Kallianinen LK; Hirshberg J; Marchant B; Rees RS Plast Reconstr Surg; 2000 Nov; 106(6):1243-8. PubMed ID: 11083552 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers: an open-label clinical evaluation of efficacy. Embil JM; Papp K; Sibbald G; Tousignant J; Smiell JM; Wong B; Lau CY Wound Repair Regen; 2000; 8(3):162-8. PubMed ID: 10886806 [TBL] [Abstract][Full Text] [Related]
11. Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation. Shackelford DP; Fackler E; Hoffman MK; Atkinson S Am J Obstet Gynecol; 2002 Apr; 186(4):701-4. PubMed ID: 11967494 [TBL] [Abstract][Full Text] [Related]
12. Treatment of avascular ulcers with cytokine-induced tissue generation and skin grafting. Brown DM; Chung SH; Pasia EN; Khouri RK Am J Surg; 1996 Feb; 171(2):247-50. PubMed ID: 8619461 [TBL] [Abstract][Full Text] [Related]
13. Original articles: ease of wound closure as an endpoint of treatment efficacy. Robson MC; Maggi SP; Smith PD; Wassermann RJ; Mosiello GC; Hill DP; Cooper DM Wound Repair Regen; 1999; 7(2):90-6. PubMed ID: 10231510 [TBL] [Abstract][Full Text] [Related]
14. Growth factors in porcine full and partial thickness burn repair. Differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and neu differentiation factor. Danilenko DM; Ring BD; Tarpley JE; Morris B; Van GY; Morawiecki A; Callahan W; Goldenberg M; Hershenson S; Pierce GF Am J Pathol; 1995 Nov; 147(5):1261-77. PubMed ID: 7485390 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. Steed DL J Vasc Surg; 1995 Jan; 21(1):71-8; discussion 79-81. PubMed ID: 7823364 [TBL] [Abstract][Full Text] [Related]
16. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial. Senet P; Vicaut E; Beneton N; Debure C; Lok C; Chosidow O Arch Dermatol; 2011 Aug; 147(8):926-30. PubMed ID: 21482863 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Becaplermin Gel Studies Group. Wieman TJ Am J Surg; 1998 Aug; 176(2A Suppl):74S-79S. PubMed ID: 9777976 [TBL] [Abstract][Full Text] [Related]
18. Re: Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Brown GL Ann Plast Surg; 1993 Feb; 30(2):192. PubMed ID: 8489189 [No Abstract] [Full Text] [Related]
19. Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee. Ladin D Plast Reconstr Surg; 2000 Mar; 105(3):1230-1. PubMed ID: 10724287 [TBL] [Abstract][Full Text] [Related]
20. Use of topical recombinant human platelet-derived growth factor-BB (becaplermin) in healing of chronic mixed arteriovenous lower extremity diabetic ulcers. Miller MS J Foot Ankle Surg; 1999; 38(3):227-31. PubMed ID: 10384364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]